Shared decision-making for cervical precancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a shared decision-making approach for women newly diagnosed with cervical precancer (CIN2). It helps you and your doctor choose the best next step together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be newly diagnosed with CIN2, a cervical precancer.
- You must be between 18 and 50 years old.
- You must not have had a previous CIN2 or worse, or a cone biopsy, in the last 2 years.
- You must not be pregnant.
- Your immune system must be healthy (no HIV, organ transplant, or other immune suppression).
- You must be able to speak and understand the local language without an interpreter.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method using low-temperature argon plasma to treat cervical precancer (CIN 2) and compares it with the standard approach of active surveillance. If you have CIN 2 and are between 18 and 40 years old, this trial may offer an alternative to watching and waiting.
This study checks cervical “pre-cancer” and cancer early using cervical screening tests. You may benefit by getting recommended results and next steps, like treatment if something concerning is found.
This trial is testing a decision aid to help women newly diagnosed with breast cancer choose between different surgery options. It looks at how well this tool supports you in making a choice that fits your values and preferences.
This study tests a new tool called PreCursor-M+® to see how well it helps doctors manage CIN2, a moderate cervical cell change. It’s for people who have already been diagnosed with CIN2 and know their HPV test results.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This study tests whether a shared decision-making approach—using decision aids and guided discussions—helps people make better choices for kidney cancer treatment. It may help you feel more informed and involved when you and your care team decide on next steps.
Hear when a new CIN2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.